---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-035667"
form_type: "8-K"
ticker: "SHPH"
cik: "0001757499"
company_name: "Shuttle Pharmaceuticals Holdings, Inc."
filed_at: "2024-09-10T23:59:59+00:00"
generated_at: "2026-05-31T05:40:25.051715+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Shuttle Pharmaceuticals borrows $250k from CEO at 12% interest, repayable in 12 months

## Summary
- Issued $250,000 promissory note to CEO Anatoly Dritschilo on September 4, 2024.
- Interest accrues at 12% per annum simple interest; principal and interest due in 12 equal monthly installments.
- Final payment due September 4, 2025; default rate increases to 20%.
- Loan proceeds provide working capital; CEO is the sole lender.

## SEC filing metadata
- accession: 0001493152-24-035667
- form_type: 8-K
- ticker: SHPH
- cik: 0001757499
- company_name: Shuttle Pharmaceuticals Holdings, Inc.
- filed_at: 2024-09-10T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1757499/000149315224035667/0001493152-24-035667-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1757499/000149315224035667/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-035667
- JSON: https://secwatch.observer/filing/0001493152-24-035667.json
- Plain text: https://secwatch.observer/filing/0001493152-24-035667.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.